Browsing by Author "Trpinac, Dusan (6602163849)"
Now showing 1 - 4 of 4
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Dermoscopy in the Diagnostics of Incontinentia Pigmenti Skin Lesions(2022) ;Minic, Snezana (35409907200) ;Dobrosavljevic, Danijela (21133925200) ;Lalosevic, Jovan (57190969635)Trpinac, Dusan (6602163849)Introduction: Incontinentia pigmenti (IP) is a rare X-linked geno-dermatosis characterized by numerous findings. Skin biopsy and histopathological analysis are considered as minor criteria for the diagnosis of IP. We assume that dermoscopy can assist the earlier diagnosis of IP. Objectives: To gain experience in earlier diagnosis of IP by observing dermoscopic findings of cutaneous changes. Methods: We revised confirmed cases of IP and examined them using dermoscopy, comparing histopathological and dermoscopic results. Results: Stage I presented solitary and grouped vesicles in linear arrangement on erythematous skin. Early stage II presented star-shaped verrucous lesions on erythematous or pigmented skin. In welldeveloped lesions, dotted vessels surround keratotic part, some with thrombosed capillaries, resembling a viral wart. Stage III presented linear brown dots on the pigmented areas. Dermoscopic image was uniform in all the examined pigmented Blaschko linear changes. Stage IV presented numerous dotted vessels on the hypopigmented skin. Terminal hair was scarce or absent in all four stages. The surrounding normal skin had perifollicular depigmentations in stages III and IV. Conclusions: Dermoscopy of all four stages is very specific compared to the dermoscopy of inflammatory dermatoses and pigmentations. Stage III has very close clinical, histological and dermoscopic mimickers and needs to be carefully examined with obligatory genetic testing. Dermoscopy of the stage IV closely corresponds to histopathological findings and may be crucial as a quick tool in revealing potential IP gene carriers. Dermoscopy should be used in addition to clinical examination since the two methods are complementary. © 2022 Minic et al. - Some of the metrics are blocked by yourconsent settings
Publication Dermoscopy in the Diagnostics of Incontinentia Pigmenti Skin Lesions(2022) ;Minic, Snezana (35409907200) ;Dobrosavljevic, Danijela (21133925200) ;Lalosevic, Jovan (57190969635)Trpinac, Dusan (6602163849)Introduction: Incontinentia pigmenti (IP) is a rare X-linked geno-dermatosis characterized by numerous findings. Skin biopsy and histopathological analysis are considered as minor criteria for the diagnosis of IP. We assume that dermoscopy can assist the earlier diagnosis of IP. Objectives: To gain experience in earlier diagnosis of IP by observing dermoscopic findings of cutaneous changes. Methods: We revised confirmed cases of IP and examined them using dermoscopy, comparing histopathological and dermoscopic results. Results: Stage I presented solitary and grouped vesicles in linear arrangement on erythematous skin. Early stage II presented star-shaped verrucous lesions on erythematous or pigmented skin. In welldeveloped lesions, dotted vessels surround keratotic part, some with thrombosed capillaries, resembling a viral wart. Stage III presented linear brown dots on the pigmented areas. Dermoscopic image was uniform in all the examined pigmented Blaschko linear changes. Stage IV presented numerous dotted vessels on the hypopigmented skin. Terminal hair was scarce or absent in all four stages. The surrounding normal skin had perifollicular depigmentations in stages III and IV. Conclusions: Dermoscopy of all four stages is very specific compared to the dermoscopy of inflammatory dermatoses and pigmentations. Stage III has very close clinical, histological and dermoscopic mimickers and needs to be carefully examined with obligatory genetic testing. Dermoscopy of the stage IV closely corresponds to histopathological findings and may be crucial as a quick tool in revealing potential IP gene carriers. Dermoscopy should be used in addition to clinical examination since the two methods are complementary. © 2022 Minic et al. - Some of the metrics are blocked by yourconsent settings
Publication Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases(2024) ;Rosain, Jérémie (56023788900) ;Voyer, Tom Le (58681065900) ;Liu, Xian (58671686500) ;Gervais, Adrian (57222020896) ;Polivka, Laura (55348398600) ;Cederholm, Axel (58686435400) ;Berteloot, Laureline (16174402700) ;Parent, Audrey V. (23486336100) ;Pescatore, Alessandra (22954304800) ;Spinosa, Ezia (57416511900) ;Minic, Snezana (35409907200) ;Kiszewski, Ana Elisa (36829537900) ;Tsumura, Miyuki (20435156200) ;Thibault, Chloé (57393783200) ;Azcoiti, Maria Esnaola (56543529300) ;Martinovic, Jelena (7006812932) ;Philippot, Quentin (56155126800) ;Khan, Taushif (56519165100) ;Marchal, Astrid (57876715800) ;Muylder, Bénédicte Charmeteau-De (58044249000) ;Bizien, Lucy (57219616192) ;Deswarte, Caroline (15822072600) ;Hadjem, Lillia (59423388900) ;Fauvarque, Marie-Odile (6603031105) ;Dorgham, Karim (6508287019) ;Eriksson, Daniel (57095712200) ;Falcone, Emilia Liana (56850172900) ;Puel, Mathilde (57914756700) ;Ünal, Sinem (59423389000) ;Geraldo, Amyrath (57219655260) ;Floc’h, Corentin Le (58919052000) ;Li, Hailun (58681201300) ;Rheault, Sylvie (57211042601) ;Muti, Christine (6602414824) ;Bobrie-Moyrand, Claire (57221800362) ;Welfringer-Morin, Anne (57195278263) ;Fuleihan, Ramsay L. (7003440477) ;Lévy, Romain (56946108200) ;Roelens, Marie (57190179406) ;Gao, Liwei (59317871200) ;Materna, Marie (57215894832) ;Pellegrini, Silvia (56533440400) ;Piemonti, Lorenzo (6603924799) ;Catherinot, Emilie (57193275770) ;Goffard, Jean-Christophe (6506658107) ;Fekkar, Arnaud (24365959200) ;Sacko-Sow, Aissata (59423177600) ;Soudée, Camille (57803366200) ;Boucherit, Soraya (35313297800) ;Neehus, Anna-Lena (56798534900) ;Has, Cristina (55874488300) ;Hübner, Stefanie (57226530504) ;Blanchard-Rohner, Géraldine (24070082100) ;Amador-Borrero, Blanca (57216634371) ;Utsumi, Takanori (57393787700) ;Taniguchi, Maki (57221963011) ;Tani, Hiroo (57193084243) ;Izawa, Kazushi (42761574600) ;Yasumi, Takahiro (6603644396) ;Kanai, Sotaro (57190375813) ;Migaud, Mélanie (37112565200) ;Aubart, Mélodie (56159372600) ;Lambert, Nathalie (56463634100) ;Gorochov, Guy (7004408016) ;Picard, Capucine (57194509265) ;Soudais, Claire (6602121088) ;L’honneur, Anne-Sophie (57193070067) ;Rozenberg, Flore (7004000569) ;Milner, Joshua D. (8335416800) ;Zhang, Shen-Ying (36019693200) ;Vabres, Pierre (7004015324) ;Trpinac, Dusan (6602163849) ;Marr, Nico (24344670100) ;Boddaert, Nathalie (57203073518) ;Desguerre, Isabelle (7003904896) ;Pasparakis, Manolis (6701908718) ;Miller, Corey N. (55812657600) ;Poziomczyk, Cláudia S. (8898247600) ;Abel, Laurent (7103216988) ;Okada, Satoshi (55256600100) ;Jouanguy, Emmanuelle (6701731774) ;Cheynier, Rémi (6603688690) ;Zhang, Qian (57201744949) ;Cobat, Aurélie (11140506200) ;Béziat, Vivien (25642778900) ;Boisson, Bertrand (23484212500) ;Steffann, Julie (6603035641) ;Fusco, Francesca (7006608197) ;Ursini, Matilde Valeria (6603768011) ;Hadj-Rabia, Smail (6603382575) ;Bodemer, Christine (7006485009) ;Bustamante, Jacinta (57201082594) ;Luche, Hervé (15822336300) ;Puel, Anne (6602102891) ;Courtois, Gilles (7004302174) ;Bastard, Paul (57219618314) ;Landegren, Nils (56649370900) ;Anderson, Mark S. (55682219200)Casanova, Jean-Laurent (7201863327)Human inborn errors of thymic T cell tolerance underlie the production of autoantibodies (auto-Abs) neutralizing type I IFNs, which predispose to severe viral diseases. We analyze 131 female patients with X-linked dominant incontinentia pigmenti (IP), heterozygous for loss-of-function (LOF) NEMO variants, from 99 kindreds in 10 countries. Forty-seven of these patients (36%) have auto-Abs neutralizing IFN-α and/or IFN-ω, a proportion 23 times higher than that for age-matched female controls. This proportion remains stable from the age of 6 years onward. On imaging, female patients with IP have a small, abnormally structured thymus. Auto-Abs against type I IFNs confer a predisposition to life-threatening viral diseases. By contrast, patients with IP lacking auto-Abs against type I IFNs are at no particular risk of viral disease. These results suggest that IP accelerates thymic involution, thereby underlying the production of auto-Abs neutralizing type I IFNs in at least a third of female patients with IP, predisposing them to life-threatening viral diseases. © 2024 Rosain et al. - Some of the metrics are blocked by yourconsent settings
Publication Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases(2024) ;Rosain, Jérémie (56023788900) ;Voyer, Tom Le (58681065900) ;Liu, Xian (58671686500) ;Gervais, Adrian (57222020896) ;Polivka, Laura (55348398600) ;Cederholm, Axel (58686435400) ;Berteloot, Laureline (16174402700) ;Parent, Audrey V. (23486336100) ;Pescatore, Alessandra (22954304800) ;Spinosa, Ezia (57416511900) ;Minic, Snezana (35409907200) ;Kiszewski, Ana Elisa (36829537900) ;Tsumura, Miyuki (20435156200) ;Thibault, Chloé (57393783200) ;Azcoiti, Maria Esnaola (56543529300) ;Martinovic, Jelena (7006812932) ;Philippot, Quentin (56155126800) ;Khan, Taushif (56519165100) ;Marchal, Astrid (57876715800) ;Muylder, Bénédicte Charmeteau-De (58044249000) ;Bizien, Lucy (57219616192) ;Deswarte, Caroline (15822072600) ;Hadjem, Lillia (59423388900) ;Fauvarque, Marie-Odile (6603031105) ;Dorgham, Karim (6508287019) ;Eriksson, Daniel (57095712200) ;Falcone, Emilia Liana (56850172900) ;Puel, Mathilde (57914756700) ;Ünal, Sinem (59423389000) ;Geraldo, Amyrath (57219655260) ;Floc’h, Corentin Le (58919052000) ;Li, Hailun (58681201300) ;Rheault, Sylvie (57211042601) ;Muti, Christine (6602414824) ;Bobrie-Moyrand, Claire (57221800362) ;Welfringer-Morin, Anne (57195278263) ;Fuleihan, Ramsay L. (7003440477) ;Lévy, Romain (56946108200) ;Roelens, Marie (57190179406) ;Gao, Liwei (59317871200) ;Materna, Marie (57215894832) ;Pellegrini, Silvia (56533440400) ;Piemonti, Lorenzo (6603924799) ;Catherinot, Emilie (57193275770) ;Goffard, Jean-Christophe (6506658107) ;Fekkar, Arnaud (24365959200) ;Sacko-Sow, Aissata (59423177600) ;Soudée, Camille (57803366200) ;Boucherit, Soraya (35313297800) ;Neehus, Anna-Lena (56798534900) ;Has, Cristina (55874488300) ;Hübner, Stefanie (57226530504) ;Blanchard-Rohner, Géraldine (24070082100) ;Amador-Borrero, Blanca (57216634371) ;Utsumi, Takanori (57393787700) ;Taniguchi, Maki (57221963011) ;Tani, Hiroo (57193084243) ;Izawa, Kazushi (42761574600) ;Yasumi, Takahiro (6603644396) ;Kanai, Sotaro (57190375813) ;Migaud, Mélanie (37112565200) ;Aubart, Mélodie (56159372600) ;Lambert, Nathalie (56463634100) ;Gorochov, Guy (7004408016) ;Picard, Capucine (57194509265) ;Soudais, Claire (6602121088) ;L’honneur, Anne-Sophie (57193070067) ;Rozenberg, Flore (7004000569) ;Milner, Joshua D. (8335416800) ;Zhang, Shen-Ying (36019693200) ;Vabres, Pierre (7004015324) ;Trpinac, Dusan (6602163849) ;Marr, Nico (24344670100) ;Boddaert, Nathalie (57203073518) ;Desguerre, Isabelle (7003904896) ;Pasparakis, Manolis (6701908718) ;Miller, Corey N. (55812657600) ;Poziomczyk, Cláudia S. (8898247600) ;Abel, Laurent (7103216988) ;Okada, Satoshi (55256600100) ;Jouanguy, Emmanuelle (6701731774) ;Cheynier, Rémi (6603688690) ;Zhang, Qian (57201744949) ;Cobat, Aurélie (11140506200) ;Béziat, Vivien (25642778900) ;Boisson, Bertrand (23484212500) ;Steffann, Julie (6603035641) ;Fusco, Francesca (7006608197) ;Ursini, Matilde Valeria (6603768011) ;Hadj-Rabia, Smail (6603382575) ;Bodemer, Christine (7006485009) ;Bustamante, Jacinta (57201082594) ;Luche, Hervé (15822336300) ;Puel, Anne (6602102891) ;Courtois, Gilles (7004302174) ;Bastard, Paul (57219618314) ;Landegren, Nils (56649370900) ;Anderson, Mark S. (55682219200)Casanova, Jean-Laurent (7201863327)Human inborn errors of thymic T cell tolerance underlie the production of autoantibodies (auto-Abs) neutralizing type I IFNs, which predispose to severe viral diseases. We analyze 131 female patients with X-linked dominant incontinentia pigmenti (IP), heterozygous for loss-of-function (LOF) NEMO variants, from 99 kindreds in 10 countries. Forty-seven of these patients (36%) have auto-Abs neutralizing IFN-α and/or IFN-ω, a proportion 23 times higher than that for age-matched female controls. This proportion remains stable from the age of 6 years onward. On imaging, female patients with IP have a small, abnormally structured thymus. Auto-Abs against type I IFNs confer a predisposition to life-threatening viral diseases. By contrast, patients with IP lacking auto-Abs against type I IFNs are at no particular risk of viral disease. These results suggest that IP accelerates thymic involution, thereby underlying the production of auto-Abs neutralizing type I IFNs in at least a third of female patients with IP, predisposing them to life-threatening viral diseases. © 2024 Rosain et al.
